Home Page

About Us

Investors

Inventors

Portfolio

Contact Us

Privacy Policy

News

Teresa Leezer Honored by Cambridge Who's Who for Excellence in Business Management

Teresa M. Leezer, Vice President of MetaCyte Business Lab LLC, has been named Cambridge Who's Who Executive of the Year in Biotechnology. While inclusion in Cambridge Who's Who Registry is an honor, only two male and two female members in each discipline are named the Cambridge Who's Who Executive of the Year. The Cambridge Who's Who selection committee chooses these special honorees based on their accomplishments, academic achievements, leadership and service.

Teresa Leezer has more than 15 years of executive management experience from Hoffman-LaRoche, Merck Labs and Bristol Myers Squibb respectively. Her experience includes the management of business units, portfolios and products in every phase of the life cycle - from pre-clinical, to launch, growth and maturity. Her sales, marketing and management expertise spans the institutional, physician and over the counter markets. Estimated launch product sales exceed $6 billion including worldwide blockbusters such as Fosamax, Zantac, Reyataz, Sustiva, Aleve and Rocephin. MetaCyte Business, Lab, LLC is a life and health science business incubator that creates and launches new companies from promising health science technologies. Ms. Leezer notes that the most rewarding aspect of her career is helping to make a difference in the world with novel ideas and technology.

Teresa's expertise includes over ten categories of medicine: osteoporosis, oncology, virology, anti-infectives, rheumatology, anesthesiology, dermatology, and pain management. She has directed significant co-marketing initiatives including the co-promotion of Zantac with Roche and Glaxo and the co-promotion of Fosamax with Merck and Wyeth-Ayerst. Teresa has also managed contract sales organizations for the promotion of products such as Flonase and Aleve.

Teresa received a Bachelor of Applied Science and a Masters of Business Administration from the University of Louisville. She attended City University, London, England. Teresa has completed Executive Management Programs at Columbia University and the University of Pennsylvania Wharton School of Business.

Teresa currently serves on the Board of Directors for RhinoCyte, Inc., the LouHie Board of Directors, the Ronald McDonald House Board of Directors and the St. Francis of Assisi School Board.






September 10, 2012
PGXL’s Software Makes Drugs More Effective (External Link)

August 23, 2012
3DR Laboratories Raises $7.2M from Advantage Capital Partners (External Link)

July 18, 2011
Louisville Will Host the 9th Annual MidAmerica Healthcare Venture Forum, November 8-9, 2011 (External Link)

October 15, 2010
Intrepid Featured on BioForm (PDF)

July 16, 2010
Intrepid Bioinformatics Receives Investment, Meets Milestones

May 6, 2010
MetaCyte Business Lab Receives Mention in Nature (PDF)

March 31, 2010
MetaCyte Recognized for Innovation

March 15, 2010
Teresa Leezer Honored a Second Time for Excellence in Business Management

February 23, 2010
Gailar Addresses Leaders as Part of Innovation Panel

January 2010
Triathlon Medical Ventures and the Kentucky Seed Capital Fund Lead Investment in Louisville Start-Up

November 2009
MetaCyte Advisor Bill Strench Featured in Business First (External Link)

November 2009
EndoProtech Awarded $270,000 from Kentucky Cabinet for Economic Development

July 1, 2009
AllTranz Named Top Innovator by National Venture Group

May 8, 2009
ApoImmune Finalist for "Best Early-Stage Vaccine Biotech" at World Vaccine Congress ViE Awards

September 12, 2008
MetaCyte Team Shows Off New Offices

June 18, 2008
Teresa Leezer Honored by Cambridge Who's Who for Excellence in Business Management

Summer 2006
A UofL research team led by Fred Roisen, Ph.D., has developed a breakthrough adult stem-cell therapy that repairs spinal-cord damage in paralyzed rats (External Link)